Studies Reveal Cell-by-Cell Changes Caused When Pig Hearts and Kidneys are Transplanted into Humans [Yahoo! Finance]
10x Genomics, Inc. (TXG)
Last 10x genomics, inc. earnings: 2/18 04:01 pm
Check Earnings Report
Company Research
Source: Yahoo! Finance
into a human body in September and November 2021 , and then transplanted two pig hearts in the summer of 2022. These procedures were done in patients declared dead based on neurologic criteria (decedents) and maintained on ventilators with the consent of their families. Demonstrating the field's progress, NYU Langone in April 2024 transplanted a pig kidney into a living patient. Now two new analyses, one published online on May 17 in Nature Medicine and the other May 21 in Med , reveal changes at the single-cell level in the organs and recipient's bodies before, during, and just after the xenotransplantation surgeries in the decedents. Teams of scientists had worked alongside the surgeons, taking blood and tissue samples to analyze changes in tens of thousands of collected cells. Led by researchers at NYU Grossman School of Medicine and the Broad Institute of MIT and Harvard , the Med paper tracked the genetic and cellular activity in the two pig kidneys transplanted into humans,
Show less
Read more
Impact Snapshot
Event Time:
TXG
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TXG alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TXG alerts
High impacting 10x Genomics, Inc. news events
Weekly update
A roundup of the hottest topics
TXG
News
- SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of 10x Genomics, Inc. (NASDAQ: TXG) and Encourages Investors to Contact the FirmAccesswire
- Moleculent Launches with $26 Million Series A Financing to Advance the Spatial Mapping of Cell-Cell Communication [Yahoo! Finance]Yahoo! Finance
- DNA Sequencing Market size is set to grow by USD 17.34 billion from 2024-2028, Growing adoption of ngs to boost the market growth, Technavio [Yahoo! Finance]Yahoo! Finance
- We Think Some Shareholders May Hesitate To Increase 10x Genomics, Inc.'s (NASDAQ:TXG) CEO Compensation [Yahoo! Finance]Yahoo! Finance
- 10x Genomics, Inc. (NASDAQ: TXG) is now covered by analysts at Jefferies Financial Group Inc.. They set a "hold" rating and a $24.00 price target on the stock.MarketBeat
TXG
Earnings
- 4/30/24 - Miss
TXG
Sec Filings
- 6/13/24 - Form 4
- 6/13/24 - Form 4
- 6/13/24 - Form 4
- TXG's page on the SEC website